Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer.

scientific article

Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PATH.4421
P698PubMed publication ID25130770

P50authorChao-Chi HoQ57009805
Wei-Yu LiaoQ57020031
Chong-Jen YuQ42255080
P2093author name stringHsuan-Yu Chen
Kuan-Yu Chen
Pan-Chyr Yang
Yung-Chie Lee
Meng-Feng Tsai
Chau-Hwang Lee
Hsin-Han Hou
Tsi-Hsuan Hsu
P2860cites workA five-gene signature and clinical outcome in non-small-cell lung cancerQ44736779
The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanismQ45061724
Signaling pathways controlling primordial germ cell migration in zebrafishQ47073985
Localization of heparin cofactor II in injured human skin: a potential role in wound healing.Q54751872
Update in lung cancer 2007Q22241904
FAM83A confers EGFR-TKI resistance in breast cancer cells and in miceQ24296333
Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesisQ24299293
Rebuilding cancer metastasis in the mouseQ26864450
Cancer statistics, 2013Q27860762
Rho GTPases in cell biologyQ27860969
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancerQ28237051
A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinomaQ28247365
RHO-GTPases and cancerQ29616099
Cell migration: Rho GTPases lead the wayQ29616711
The emerging mechanisms of isoform-specific PI3K signallingQ29617954
In silico analysis of gastric carcinoma Serial Analysis of Gene Expression libraries reveals different profiles associated with ethnicityQ30841507
Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression dataQ31120561
A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.Q33286794
An anatomy of normal and malignant gene expressionQ34037920
Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway.Q34384055
Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycansQ36263562
Heparin cofactor II modulates the response to vascular injuryQ36694763
Modification of the 85-kilodalton subunit of phosphatidylinositol-3 kinase in platelet-derived growth factor-stimulated cellsQ36821017
Lamellipodia and filopodia in metastasis and invasionQ37132020
Rho GTPases in cancer cell biologyQ37156024
Phosphoinositide 3-kinases in cell migrationQ37340915
Antimetastatic activities of heparins and modified heparins. Experimental evidence.Q37740310
Nucleating actin for invasionQ37843451
Label-free quantification of asymmetric cancer-cell filopodium activities in a multi-gradient chip.Q39871624
Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinaseQ40808012
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancerQ42598009
Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissuesQ43588743
P433issue1
P304page(s)50-64
P577publication date2014-10-01
P1433published inJournal of PathologyQ400296
P1476titleHeparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
P478volume235

Reverse relations

cites work (P2860)
Q40714729Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase
Q54993659Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
Q46538048Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells
Q47283163Elevated hydrostatic pressure enhances the motility and enlarges the size of the lung cancer cells through aquaporin upregulation mediated by caveolin-1 and ERK1/2 signaling
Q90151818Serine protease inhibitors and human wellbeing interplay: new insights for old friends
Q64262527Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy
Q58796079The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD

Search more.